Pharmafile Logo

Radcliffe Cardiology

Radcliffe Cardiology is an innovative media and publishing company that aims to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Springer Nature

Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote your approved branded drugs and medical devices to our audience…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.

View Profile

Company Details

7/8 Woodlands Farm, Cookham Dean, Berkshire, SL6 9PN, UK

 Latest Content from PMHub 

OPEN Health Appoints Tim Perryman as Global Head of Operations to Strengthen Operational Excellence and Support Global Growth

Press Releases | March 18, 2026 | OPEN Health

OPEN Health today announced the appointment of Tim Perryman as Global Head of Operations, strengthening the company’s operational leadership as it continues to scale its global capabilities and support clients...

OPEN Health Appoints Peter Black as EVP, Global Client Partner and Transformation Lead to Accelerate Global Client Partnerships and Digital Innovation

Press Releases | March 18, 2026 | OPEN Health

OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.

OPEN Health Appoints Cara Priest as Chief People Officer to Strengthen Culture, Capability and Organisational Performance

Press Releases | March 18, 2026 | OPEN Health

OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and scientific excellence.

Smarter Learning and Better Outcomes: How AI Can Provide an Advantage in Medical Education

Press Releases | March 12, 2026 | Impetus Digital

See how AI-powered patient avatars allow physicians to test complex diagnoses and treatment plans in a simulated environment.

Webinar: What do HCPs really want from pharma digital in 2026?

Our research shows that healthcare professionals are not disengaging from pharma digital. They are becoming more selective about the experiences that earn their attention. To explore what this means for...

Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.

At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...

AI in practice: 4 real-world use cases in health and life sciences

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...

A Pharma Brand Manager’s Guide to Exhibiting

Securing your exhibition space is a significant milestone. The contract is signed, the floorplan is confirmed and the event is in the calendar. So what happens next? Exhibiting successfully involves...

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Why stigma is a launch risk in rare disease – and what commercial leaders can do about it

Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.